Anlon HealthcareNSE:AHCL +1.96%17 EBIT per Share is ₹32.59 as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review. Among 810 Drug Manufacturers companies, Anlon Healthcare ranks better than 95.19% on this metric.
Anlon Healthcare's EBIT per Share for the
three
months ended in Mar. 2026 was ₹32.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹32.59.
During the past 12 months, the average EBIT per Share Growth Rate of Anlon Healthcare was 72.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 68.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Anlon Healthcare's EBIT per Share or its related term are showing as below:
NSE:AHCL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 68 Med: 84.75 Max: 101.5
Current: 68
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Anlon Healthcare was 101.50% per year. The lowest was 68.00% per year. And the median was 84.75% per year.
NSE:AHCL's 3-Year EBIT Growth Rate is ranked better than 95.19% of 810
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs NSE:AHCL: 68.00
Anlon Healthcare's EBIT for the
three
months ended in Mar. 2026 was ₹14,449 Mil.
Anlon Healthcare (NSE:AHCL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Anlon Healthcare EBIT per Share Related Terms
Anlon Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹32.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anlon Healthcare (NSE:AHCL) has a EBIT per Share of ₹32.59 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Anlon Healthcare and its competitors. According to the industry distribution chart, Anlon Healthcare ranks #39 out of 810 companies in the Drug Manufacturers industry, placing it in the top 4.8%.
Is Anlon Healthcare's EBIT per Share too high?
Anlon Healthcare's current EBIT per Share is ₹32.59. Based on the distribution chart, Anlon Healthcare ranks #39 out of 810 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Anlon Healthcare ranks #39 out of 810 companies for EBIT per Share. This places Anlon Healthcare in the top 5% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Anlon Healthcare and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anlon Healthcare's current EBIT per Share is ₹32.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current EBIT per Share of ₹32.59. The current EBIT per Share is ₹32.59. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current EBIT per Share is ₹32.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score
Get the complete analysis for NSE:AHCL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
